Once cancer has metastasized and spread throughout the body, the end is near—and very, very painful. However, a new therapy that utilizes cannabidiol (CBD) has shown promising results in turning back the clock on invasiveness of late-stage breast cancer.
In a study funded in part by National Institutes of Health, molecular biologists at the California Pacific Medical Center performed tests on human breast cancer cells that reveal how CBD could slow down and even halt the progression of the disease, even at its more virulent late-stage existence.
For breast cancer sufferers, this is huge news. Despite the overwhelming public support of breast cancer patients and sky-high donations to specifically focused charities like the Susan G. Komen Foundation, breast cancer remains an insidious killer. The American Cancer Society that the average American woman has a 12 percent chance of developing breast cancer in her lifetime—more than any other cancer besides skin cancer.
Comments will be approved before showing up.
NEW PRODUCT ALERT
Our New BodyChek Wellness Broad-Spectrum CBD products contain various compounds and cannabinoids from the cannabis plant, such as cannabichromene (CBC), cannabinol (CBN), cannabigerol (CBG), and terpenes, such as myrcene, limonene, or pinene.